Skip to main content
Springer Nature - PMC COVID-19 Collection logoLink to Springer Nature - PMC COVID-19 Collection
. 2006;30(8):863–872. doi: 10.1007/s11259-006-3373-6

Evaluation of a Commercially Available Human Serum Amyloid A (SAA) Turbidimetric Immunoassay for Determination of Feline SAA Concentration

A E Hansen 1, M K Schaap 1, M Kjelgaard-Hansen 1,
PMCID: PMC7089358  PMID: 17139536

Abstract

Serum amyloid A (SAA) is an acute-phase protein in cats likely to be useful for diagnosing and monitoring inflammatory diseases, especially if rapid, reliable and automated assays can be made available. A commercially available automated human SAA turbidimetric immunoassay (SAA-TIA) was evaluated for determination of SAA in cats. Intra-assay and inter-assay imprecisions were in the ranges 2.1–9.9% and 7.0–12.5%, respectively, and without significant inaccuracy. Eighty-eight cats were divided into groups according to (A) the presence or absence of an acute-phase response (APR) (n = 23 and 65, respectively) and (B) clinical diagnosis (clinically healthy cats, cats diagnosed with inflammatory/infectious diseases, endocrine/metabolic diseases, neoplastic diseases, and miscellaneous disorders (n=43, 13, 8, 4 and 20, respectively)). The observed SAA concentrations were, as expected, different for (A) cats with and without an APR and (B) cats with inflammatory/infectious diseases compared to other diagnostic groups, except neoplastic diseases. In conclusion, the SAA concentration in cats could be measured reliably using the commercially available TIA designed for measuring human SAA, which should facilitate implementation of the parameter for routine diagnostic purposes.

Keywords: acute-phase protein, cat, immunoassay, inflammation, serum amyloid A, test validation

Abbreviations

AGP

α1-acid glycoprotein

APR

acute-phase response

CI

confidence interval

CV

coefficient of variation

DSH

domestic short hair

FLUTD

feline lower urinary tract disease

SAA

serum amyloid A

SD

standard deviation

TIA

turbidimetric immunoassay

Footnotes

Hansen, A.E., Schaap, M.K. and Kjelgaard-Hansen, M., 2006. Evaluation of a commercially available human serum amyloid A (SAA) turbidimetric immunoassay for determination of feline SAA concentration. Veterinary Research Communications, 30(8), 863–872

References

  1. Box G.E.P., Hunter W.G., Hunter J.S. Statistics for Experimenters. New York: Wiley; 1978. [Google Scholar]
  2. Büttner J., Borth R., Boutwell H.J., Broughton P. International federation of clinical chemistry. Approved recommendation (1978) on quality control in clinical chemistry. Part 2. Assessment of analytical methods for routine use. Journal of Clinical Chemistry and Clinical Biochemistry. 1980;18:78–88. [Google Scholar]
  3. DiBartola S.P., Reiter J.A., Cornacoff J.B., Kociba G.J., Benson M.D. Serum amyloid A protein concentration measured by radial immunodiffusion in Abyssinian and non-Abyssinian cats. American Journal of Veterinary Research. 1989;50:1414–1417. [PubMed] [Google Scholar]
  4. Eckersall P.D. The time is right for acute-phase protein assays. Veterinary Journal. 2004;168:3–5. doi: 10.1016/j.tvjl.2003.09.003. [DOI] [PubMed] [Google Scholar]
  5. Gabay C., Kushner I. Acute-phase proteins and other systemic responses to inflammation. New England Journal of Medicine. 1999;340:448–454. doi: 10.1056/NEJM199902113400607. [DOI] [PubMed] [Google Scholar]
  6. Ganz P.A., Shell W.E., Tokes Z.A. Evaluation of a radioimmunoassay for alpha 1-acid glycoprotein to monitor therapy of cancer patients. Journal of the National Cancer Institute. 1983;71:25–30. [PubMed] [Google Scholar]
  7. Giordano A., Spagnolo V., Colombo A., Paltrinieri S. Changes in some acute-phase protein and immunoglobulin concentrations in cats affected by feline infectious peritonitis or exposed to feline coronavirus infection. Veterinary Journal. 2004;167:38–44. doi: 10.1016/S1090-0233(03)00055-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Jensen A.L. Validation of diagnostic test in hematology laboratories. In: Feldmann B.V., Zinkl L.G., Jain N.C., editors. Schalm's Veterinary Hematology. Philadelphia: Lippincott Williams and Wilkins; 2000. pp. 20–28. [Google Scholar]
  9. Jensen A.L., Bomholt M., Moe L. Preliminary evaluation of a particle-enhanced turbidimetric immunoassay (PETIA) for the determination of serum cystatin C-like immunoreactivity in dogs. Veterinary Clinical Pathology. 2001;30:86–90. doi: 10.1111/j.1939-165x.2001.tb00263.x. [DOI] [PubMed] [Google Scholar]
  10. Jensen L.E., Whitehead A.S. Regulation of serum amyloid A protein expression during the acute-phase response. Biochemical Journal. 1998;334(3):489–503. doi: 10.1042/bj3340489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Kajikawa T., Furuta A., Onishi T., Sugii S. Enzyme-linked immunosorbent assay for detection of feline serum amyloid A protein by use of immunological cross-reactivity of polyclonal anti-canine serum amyloid A protein antibody. Journal of Veterinary Medical Science. 1996;58:1141–1143. doi: 10.1292/jvms.58.11_1141. [DOI] [PubMed] [Google Scholar]
  12. Kajikawa T., Furuta A., Onishi T., Tajima T., Sugii S. Changes in concentrations of serum amyloid A protein, alpha 1-acid glycoprotein, haptoglobin, and C-reactive protein in feline sera due to induced inflammation and surgery. Veterinary Immunology and Immunopathology. 1999;68:91–98. doi: 10.1016/S0165-2427(99)00012-4. [DOI] [PubMed] [Google Scholar]
  13. McDonald T.L., Weber A., Smith J.W. A monoclonal antibody sandwich immunoassay for serum amyloid A (SAA) protein. Journal of Immunological Methods. 1991;144:149–155. doi: 10.1016/0022-1759(91)90081-P. [DOI] [PubMed] [Google Scholar]
  14. Sasaki K., Ma Z., Khatlani T.S., Okuda M., Inokuma H., Onishi T. Evaluation of feline serum amyloid A (SAA) as an inflammatory marker. Journal of Veterinary Medical Science. 2003;65:545–548. doi: 10.1292/jvms.65.545. [DOI] [PubMed] [Google Scholar]
  15. Selting K.A., Ogilvie G.K., Lana S.E., Fettman M.J., Mitchener K.L., Hansen R.A., Richardson K.L., Walton J.A., Scherk M.A. Serum alpha 1-acid glycoprotein concentrations in healthy and tumor-bearing cats. Journal of Veterinary Internal Medicine. 2000;14:503–506. doi: 10.1892/0891-6640(2000)014<0503:SAGCIH>2.3.CO;2. [DOI] [PubMed] [Google Scholar]
  16. Siegel S.C.N.J. Nonparametric Statistics for the Behavioural Sciences. New York: McGraw-Hill; 1998. [Google Scholar]
  17. Solberg H.E. Establishment and use of reference values. In: Burtis C.A., Ashwood E.R., editors. Tietz' Fundamentals of Clinical Chemistry. Philadelphia: W.B. Saunders; 1996. pp. 182–192. [Google Scholar]
  18. Steel D.M., Whitehead A.S. The major acute-phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunology Today. 1994;15:81–88. doi: 10.1016/0167-5699(94)90138-4. [DOI] [PubMed] [Google Scholar]
  19. Uhlar C.M., Whitehead A.S. Serum amyloid A, the major vertebrate acute-phase reactant. European Journal of Biochemistry. 1999;265:501–523. doi: 10.1046/j.1432-1327.1999.00657.x. [DOI] [PubMed] [Google Scholar]

Articles from Veterinary Research Communications are provided here courtesy of Nature Publishing Group

RESOURCES